Digimed
71-63-6CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CCC5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1OWDJUZGPOPHTGOT-UHFFFAOYSA-Ndigitoxin has been reported in Digitalis cariensis, Digitalis lanata, and Adenium obesum with data available.
71-63-6CHEMBL267817白色或类白色结晶性粉末。熔点256-257℃。溶于酸、氯仿、丙酮和吡啶,微溶于水及石油醚。无臭,味苦。从稀醇中结晶常含有半分子或一分子结晶水或结合一分子乙醇。真空加热至118℃可转为无水物。
安全信息仅供参考,不能替代供应商安全技术说明书(SDS)、适用法规与专业评估。
急性毒性口服- 大鼠 LD50 23.75 毫克/ 公斤; 口服- 小鼠 LD50: 4.95 毫克/公斤
刺激数据眼-狗 1%/24小时 阳性
可燃性危险特性可燃, 火场排出辛辣刺激烟雾
储运特性库房低温, 通风, 干燥; 与食品原料分开存放
灭火剂水, 二氧化碳, 干粉, 砂土
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
用途该品与地高辛(异羟基洋地黄毒甙)相同,能加强心肌收缩力,减慢心率和抑制传导。其特点是作用开始慢而持久,适用于慢性心功能不全患者长期服用。该品不可与酸碱类药物配伍。该品对豚鼠、猫的口服LD50分别为60.0和0.18mg/kg。
生产方法自然界中,洋地黄叶及其他强心性生药的有效成分为甾体粮甙,动物中蟾蜍的分泌物中也含有同类的物质。洋地黄毒甙分子中,糖结合顺洋地黄毒甙配套([143-62-4])C3的羟基上。粮苷配基带有丁烯内酯结构。医药工业中,将洋地黄叶粉加水在28-35℃发醇,用70%乙醇提取发酵叶粉,浓缩、过滤。取浓缩液在28-30℃去胶4-6h,再用氯仿提取。提取液依次用水、5%氢氧化钠溶液、水洗涤,浓缩至粘稠状,加无水丙酮结晶,在0-5℃放置过夜,过滤得湿品。再经柱上层析精制和洋地黄毒甙。